How to Choose an AI Partner for Pharma (Without Getting Burned)

The pharma AI market is flooded with vendors promising transformation. Most deliver PowerPoint.

Here's the reality: according to industry data, 83% of AI pilots in pharma never reach production. The gap between "impressive demo" and "works with our data, our compliance requirements, and our team" is enormous.

This guide gives you a practical framework to evaluate AI partners before you spend six figures finding out they can't deliver.

The 7 Questions That Matter

1. "Show me a pharma deployment, not a demo"

• A reference customer in pharma (not healthcare broadly — pharma specifically)
• The deployment timeline (if it took 12 months, your "3-month pilot" will too)
• The compliance review process they followed
• What failed during implementation and how they fixed it

🚩 Red flag: "We're working on our first pharma client" — you're paying for their education.

2. "Where does our data live?"

• On-premise option: Can the system run entirely within your infrastructure?
• Data residency: For EU companies, data must stay in EU (GDPR Article 44+)
• Subprocessors: Who else touches your data? OpenAI? AWS? A startup's GPU cluster?
• Data retention: What happens to your data after the contract ends?

🚩 Red flag: "We send data to our API" with no clarity on where that API lives.

3. "What happens when the AI is wrong?"

• Audit trail: Can you trace every AI output back to its sources?
• Confidence scoring: Does the system flag low-confidence outputs for human review?
• Escalation paths: What triggers automatic escalation to a human?
• Error rate reporting: Do they measure and report accuracy systematically?

🚩 Red flag: "Our AI is 99% accurate" — anyone claiming this hasn't tested with real pharma data.

4. "How does it handle regulatory updates?"

• Knowledge refresh: How quickly does the system incorporate new information?
• Version control: Can you see which version of a document the AI used?
• Automatic flagging: Does it alert when source documents are updated?
• Rollback capability: Can you revert to a previous knowledge state if needed?

🚩 Red flag: "We update the model quarterly" — pharma moves faster than that.

5. "What does your team look like?"

• Regulatory expertise: Does anyone on the team understand GxP, 21 CFR Part 11, EU MDR?
• Therapeutic area knowledge: Can they discuss your specific TA intelligently?
• Implementation team: Who actually builds and deploys — senior engineers or juniors?
• Post-launch support: What happens after go-live? SLA response times?

🚩 Red flag: "Our AI handles everything automatically" — in pharma, nothing is fully automatic.

6. "What's the total cost?"

• License fees: Monthly/annual, per-user or per-query?
• Implementation costs: Often 2–5x the annual license fee
• Integration work: Connecting to your EDMS, CTMS, CRM
• Internal resources: How many FTEs do you need to dedicate?
• Scaling costs: What happens when volume doubles?

🚩 Red flag: "We'll scope that after the pilot" — scope it now or pay later.

7. "Can we start small?"

• Pilot scope: One workflow, one team, 3–4 weeks — not a 6-month "discovery phase"
• Success criteria: Agreed KPIs before the pilot starts
• Exit clause: What if it doesn't work? Can you walk away?
• Data portability: If you leave, do you keep your configurations and training data?

🚩 Red flag: "We need 6 months to understand your environment" — this means they don't have a repeatable methodology.

The Evaluation Scorecard

Score each vendor 1–5 on these criteria:

Criteria	Weight	Score
Pharma domain expertise	25%	/5
Data security & GDPR compliance	20%	/5
Audit trail & traceability	15%	/5
Implementation speed	15%	/5
Pricing transparency	10%	/5
Integration capabilities	10%	/5
Reference customers	5%	/5

A vendor scoring below 3.5 weighted average isn't ready for pharma.

The Bottom Line

The best AI partners for pharma share three traits: 1. They start small — proving value in weeks, not months 2. They know pharma — not just AI, but your regulatory reality 3. They measure everything — KPIs from day one, not promises for quarter four

Don't buy a platform. Buy a result. Then scale.

---

*kureus scores 4.8 on our own scorecard — because we built it based on what pharma teams actually need. Test us with a 20-minute diagnosis →*